1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intracardiac Echocardiography Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intracardiac Echocardiography Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Regulatory Scenario by Region/Globally
5.4. Reimbursement Scenario by Region/Globally
5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
6. Global Intracardiac Echocardiography Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Radial or Rotating ICE
6.3.2. Phased-array ICE
6.4. Market Attractiveness Analysis, by Type
7. Global Intracardiac Echocardiography Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Electrophysiology
7.3.2. Left Atrial Appendage Closure
7.3.3. Transcatheter Aortic Valve Implantation
7.3.4. Atrial Septal Defect
7.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Intracardiac Echocardiography Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others (Clinics and Cardiac Centers, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Intracardiac Echocardiography Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Intracardiac Echocardiography Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. Radial or Rotating ICE
10.2.2. Phased-array ICE
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Electrophysiology
10.3.2. Left Atrial Appendage Closure
10.3.3. Transcatheter Aortic Valve Implantation
10.3.4. Atrial Septal Defect
10.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others (Clinics and Cardiac Centers, etc.)
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Intracardiac Echocardiography Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. Radial or Rotating ICE
11.2.2. Phased-array ICE
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Electrophysiology
11.3.2. Left Atrial Appendage Closure
11.3.3. Transcatheter Aortic Valve Implantation
11.3.4. Atrial Septal Defect
11.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others (Clinics and Cardiac Centers, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Intracardiac Echocardiography Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Radial or Rotating ICE
12.2.2. Phased-array ICE
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Electrophysiology
12.3.2. Left Atrial Appendage Closure
12.3.3. Transcatheter Aortic Valve Implantation
12.3.4. Atrial Septal Defect
12.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others (Clinics and Cardiac Centers, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Intracardiac Echocardiography Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Radial or Rotating ICE
13.2.2. Phased-array ICE
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Electrophysiology
13.3.2. Left Atrial Appendage Closure
13.3.3. Transcatheter Aortic Valve Implantation
13.3.4. Atrial Septal Defect
13.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others (Clinics and Cardiac Centers, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Intracardiac Echocardiography Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Radial or Rotating ICE
14.2.2. Phased-array ICE
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Electrophysiology
14.3.2. Left Atrial Appendage Closure
14.3.3. Transcatheter Aortic Valve Implantation
14.3.4. Atrial Septal Defect
14.3.5. Others (MitraClip Implantation and Mitral Valvuloplasty, etc.)
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others (Clinics and Cardiac Centers, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Siemens Healthineers
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Koninklijke Philips N.V.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Abbott
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Johnson & Johnson (Medical Device Business Services, Inc.)
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Boston Scientific Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. GE HealthCare
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Stryker Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Type Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Stereotaxis, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Type Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Shifamed, LLC
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Type Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
